Adaptation of hepatitis C virus (HCV) to CD8 + T cell selection pressure is well described; however, it is unclear if HCV differentially adapts in different populations.
| INTRODUC TI ON
Globally, an estimated 71 million people have chronic hepatitis C virus (HCV) infection. 1 Although great success has been achieved in the antiviral therapy of chronic hepatitis C (CHC), 2 the lack of an effective prophylactic vaccine and the expensive cost for treatment make CHC a major health burden in developing countries. Several studies suggest that robust HCV-specific CD8 + T cell responses directed at multiple epitopes are important for viral control. [3] [4] [5] [6] Many vaccine candidates in current preclinical and clinical development therefore aim to efficiently activate T cells. [7] [8] [9] One of the major obstacles to vaccine development is the inherent sequence diversity of HCV. 10 Due to the lack of a proofreading function in the NS5B
polymerase, HCV exists in the human host as a quasispecies with distinct variants. 11 The quasispecies nature of HCV enables rapid adaptation to changes in the replication environment. Accordingly, the rapid selection of variants by targeting cytotoxic T lymphocyte (CTL) epitopes is well documented and potentially associated with failure of immune control. [12] [13] [14] CTL epitopes are presented by HLA class I molecules on the surface of an infected cell. Allelic variation at the HLA class I gene loci enables the binding and presentation of multiple different peptides derived from intracellular proteins. The enormous diversity of HLA class I molecules expressed in a population limits a pathogen's ability to evade immune pressure through adaptation to any individual host. Co-evolution of HLA class I-encoding genes with pathogens in a population was proposed as a driving force for this HLA diversity. 15, 16 Of note, there are marked differences in the frequency of distinct HLA class I alleles within a single population but also between the frequencies of these alleles in distinct populations and different ethnic groups. Such differences between ethnic groups are the basis for the use of different T cell repertoires against viral infections.
17,18
At the population level, reproducible escape in CD8 epitopes in subjects sharing the same restricting HLA class I allele drives associations between viral sequence polymorphisms and particular HLA alleles. [19] [20] [21] Host-to-host transmission of viral strains adapted to immune pressure has important consequences for vaccine development. Continuous accumulation of an escape mutation in a CD8 epitope in circulating isolates may eventually lead to deletion of the target antigen from the population. In support of this hypothesis, adaptation to the immune pressure of individual epitopes in the majority of circulating isolates was demonstrated in EBV and HIV. 22, 23 In HIV, a fascinating observation suggested that expression of rare HLA alleles is a selection advantage and associated with lower viral load, presumably because circulating isolates may have adapted to frequent HLA alleles in a population. 24, 25 In HCV, we similarly reported a relatively stable escape mutation in an immunodominant CD8 epitope in NS3 that replaced the immunogenic prototype epitope sequence in the majority of circulating isolates in Europe. 19 In a vaccine, such immune targets would likely be less efficient in providing protective immunity, as the relevant antigen is not present in most viral isolates.
The aim of this study was to address whether the adaptation of viral sequences to immune pressure is influenced by the HLA background of the host population. We sequenced HCV NS3 (genotype 1b) from circulating isolates in China and compared their sequences with the sequences of isolates from Germany. We utilized an algorithm to identify polymorphic sites that differ in isolates from these populations and compared viral substitution patterns between isolates from Chinese and German populations. By this approach, we found evidence for differential adaptation to the immune pressure of circulating HCV isolates in HLA-diverse populations.
| MATERIAL S AND ME THODS

| Patients
All Chinese patients were recruited at the outpatient department of 
| PCR and sequencing of NS3
PCR and sequencing of the NS3 gene from 89 patient samples were performed in two overlapping fragments, essentially as previously described. 19 
| HLA typing
| Analysis of associations between mutations and HLA class I alleles
The majority of consensus sequences were generated for Chinese and German isolates and served as references. Residues under selection pressure in the presence of individual HLA class I alleles were identified in a statistical approach utilizing the analysis tool SeqFeatR. 27 
| Analysis of the CD8 + T cell response
Antigen-specific T cells were expanded from cryopreserved HLA-A*11-and A*03-positive PBMCs. Synthetic peptides were purchased from EMC, Tubingen, Germany. PBMCs were cultured in R10 medium (RPMI 1640 medium containing 10% foetal calf serum, 100 U/mL penicillin, 100 μg/mL streptomycin, 10 mmol/L HEPES buffer and 25 U/mL recombinant interleukin-2) and stimulated with different prototype peptides (1 μg/mL per peptide) and 0.1 μg/mL anti-CD28 and antiCD49d. On day 7, medium containing IL-2 was added. On day 10, the cells were restimulated with the prototype or variant peptides in the presence of brefeldin A (100 ng/mL) for 4 hours, and the frequency of IFNγ-secreting CD8 + T cells was analysed via flow cytometry. All samples were acquired using a FACS Canto (BD), and the data were analysed using FlowJo software (Tree Star Inc., Ashland, OR, USA)
| Statistical analysis
All statistical tests were performed using GraphPad Prism 5.0 software (GraphPad Software, San Diego, CA, USA).
| RE SULTS
| Phylogenetic analysis revealed two distinct clades in Chinese isolates
The complete NS3 region was sequenced from 89 Chinese and 96
German patients. Phylogenetic analyses of isolates from China and
Germany together with additional sequences from a large singlesource outbreak were performed. Interestingly, the Chinese sequences fell into two phylogenetically distinct clusters (Figure 1 ), suggesting a founder effect with at least two GT1b origins in China.
The genetic distance between isolates within these two Chinese clusters was similar to the distance between isolates of the "East 
| Differential escape of HCV from CD8 + T cell selection pressure between China and Germany
We compared the Chinese and German HLA-A and HLA-B allele frequencies in our cohort with data from the HLA database. 31 While only minor differences between the reported frequencies of common HLA class I alleles and the observed frequencies in our cohorts were present, there were substantial differences between the frequencies in China and Germany. The most frequent (Table S1 ). TA B L E 1 Substitutions in described CD8 T cell epitopes with statistical support for selection pressure F I G U R E 2 Frequency of HLA-A*11 and HLA-A*03 associated sequence polymorphisms in the NS3 [1635] [1636] [1637] [1638] [1639] [1640] [1641] [1642] [1643] . A, The frequencies of variations from the consensus sequence in isolates from China (light grey) and Germany (dark grey) are shown. B and C, The frequency of variations from the consensus sequence in viral isolates from China from individuals carrying HLA-A*11 (dark grey) and individuals lacking HLA-A*11 (white) is shown for each position. In C, the frequency of variations from the amino acids isoleucine and threonine in position is shown. D and E, The frequency of variations from the consensus sequence in viral isolates from Germany from individuals carrying HLA-A*03 (dark grey) and individuals lacking HLA-A*03 (white) is shown for each position. In E, the frequency of variations from the amino acids isoleucine and threonine in position is shown. P-values were calculated with a Fisher's exact test Given the evidence of HLA class I adaptation of HCV at the population level, 19, 20, 32 whether similar adaptation has occurred in Chinese isolates was addressed. We first analysed if viral sequence polymorphisms inside known CD8 T cell epitopes were statistically more frequent in the presence of the relevant HLA class I allele than in the absence of the relevant allele. The results are summarized in Table 1 . In three previously described epitopes of NS3, there was statistical evidence for immune selection pressure on viral isolates from China by CD8 T cells. Notably, although the HLA-B*58-restricted epitope has been previously described in a Caucasian patient, there has been no evidence for immune selection. 33 The HLA-B*51-restricted epitope is also under selection pressure in German isolates, although a different substitution is selected in genotype 1b. One epitope region was particularly interesting because it was described to be presented by HLA-A*03 as well as HLA-A*11
(VTLTHPITK [1635] [1636] [1637] [1638] [1639] [1640] [1641] [1642] [1643] ). In China, the substitution V1635I is selected in the presence of HLA-A*11, while in Germany, the substitution Figure 2E ). In position 1641 sequence variants are more frequent in Germany (27.1%) than in China (6.5%). Here, the most frequent substitution (I1641V) was selected in the presence of HLA-A*03 (P = 0.0037; Figure 2D ).
Taken together, we identified three HLA class I-restricted epitopes in HCV NS3 with statistical support for selection pressure and found evidence for distinct escape pathways between isolates from China and Germany depending on the presenting HLA class I molecule. 
| Substitutions
| D ISCUSS I ON
The ability of HCV to adapt to immune pressure by selection of mutations conferring resistance to components of the adaptive immune system within one infected individual is well documented. 10, 12, 14 Previous studies suggested that cellular immune selection pressure can be reproducible at the population level, resulting in "HLA class I footprints" in sequences of circulating isolates. 19, 21, 37 Here, we extend this analysis to sequences from different geographic regions and with host populations with HLA class I backgrounds.
One epitope region was particularly interesting because it was presented by two different HLA class I molecules, one that is frequent in Germany (HLA-A*03) but rare in China and one that is highly prevalent in China (HLA-A*11) but rare in Germany. In the context of HLA-A*11, the epitope was originally described as an 8-mer 36 ; however, in our hands, no CD8 T cell response was detected against the 8-mer. In contrast, the N-terminally elongated 9-mer was targeted by CD8 T cells. Notably, the most frequent consensus residue in po- Opposing selection forces on the same residue that depend on the presenting HLA class I allele have been described in HIV and HCV. 40 Negative selection pressure on isoleucine in position 1636 due to fitness constraints seems less likely, given that the accumulation of this substitution has occurred in China. However, it is possible that the genome plasticity depends on the larger sequence context and that the T1636I substitution is less fit in the context of GT1b
isolates from Germany and more fit in the context of GT1b isolates from China. In line with this reasoning, clade-specific differences in the functional constraints associated with different escape pathways has been described for HIV. 41 In the phylogenetic tree of the HCV sequences, the Chinese isolates form two separate clusters that are possibly associated with different sequence constraints.
Unfortunately, the relevance of individual substitutions for viral fitness in different genetic GT1b backgrounds is difficult to address in cell culture experiments, as only few GT1b isolates support replication in vitro. 42 The phylogenetic tree confirms previous observations suggesting the rapid spread of individual GT1b isolates between 1960 and 1990 in China. 29, 30 In line with this possibility, the genetic distance between Chinese isolates is similar to the genetic distance between isolates from a large HCV GT1b outbreak that occurred in the former German Democratic Republic between 1977/78. 28 Accordingly, founder effects in China may play a role for sequence differences between isolates from Germany and China. 43 It is possible that the transmission and rapid spread of a few isolates carrying the T1636I substitution resulted in different consensus sequences in Germany and China. Nevertheless, the impact of the substitution on the immune response in the context of the highly prevalent allele HLA-A*11 in China may have promoted the transmission of this viral variant.
It was previously reported in a large HCV genotype 1b outbreak in Ireland that HLA-A*03 is associated with spontaneous clearance of HCV infection. 44 The protective effect was linked to targeting of a dominant epitope located in NS3 (TVYHGAGTK) and fitness costs associated with individual escape mutations requiring additional compensatory mutations. 45, 46 Notably, the protective effect was exclusively observed in the Irish outbreak and not in a similar HCV genotype 1b outbreak in East Germany, possibly because the immunodominant target in NS3 differed between the sources of these outbreaks. 40 There are no data available suggesting that HLA-A*11 has a differential impact on the outcome of HCV infection; however, no such studies have been performed in Asian cohorts. Reproducible selection pressure on different residues within the epitope and a complex escape pathway, as observed here for HLA-A*11, would be consistent with a beneficial effect of HLA-A*11 for disease outcome.
Collectively, our data are consistent with differential escape pathways selected by HCV in the context of different HLA class I alleles. This result has important implications for vaccine design against highly variable and globally distributed pathogens. Our results suggest that pathogens such as HCV differentially adapt in HLA-diverse populations, which may require matching antigen sequences to geographic regions for T cell-based vaccine strategies. 
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